Sign In
Buy PACB
$1.15
-0.0350 (-2.95%)
At Close: Aug 10, 2026
PacBio Q2 Earnings Meet Estimates, Revenues Miss, 2026 Sales View Cut
02:06pm, Thursday, 06'th Aug 2026
PACB cuts its 2026 revenue outlook after Q2 sales fall 2%, as consumables and EMEA growth fail to offset weaker instruments and Asia-Pacific.
Pacific Biosciences: It's Only Getting Worse
01:41am, Thursday, 06'th Aug 2026
Pacific Biosciences reported Q2 revenues of $39.01 million, missing estimates and guiding 2026 revenues down, below consensus. Operating and net losses remain sizable, with cash now under $237 million
Pacific Biosciences of California, Inc. (PACB) Q2 2026 Earnings Call Transcript
01:30am, Thursday, 06'th Aug 2026
Pacific Biosciences of California, Inc. (PACB) Q2 2026 Earnings Call Transcript
Pacific Biosciences of California Q2 Earnings Call Highlights
12:04am, Thursday, 06'th Aug 2026
Pacific Biosciences of California NASDAQ: PACB reported second-quarter 2026 revenue of $39 million, roughly flat from $39.8 million a year earlier, while announcing an immediate leadership transition
Pacific Biosciences of California (PACB) Reports Q2 Loss, Lags Revenue Estimates
07:11pm, Wednesday, 05'th Aug 2026
Pacific Biosciences of California (PACB) came out with a quarterly loss of $0.14 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.13 per share a year ago.
PacBio Appoints Mark Van Oene as President and Chief Executive Officer
04:08pm, Wednesday, 05'th Aug 2026
Christian Henry to Transition from President and Chief Executive Officer Following Six Years of Leadership; Effective August 5, 2026 Christian Henry to Transition from President and Chief Executive Of
PacBio Announces Second Quarter 2026 Financial Results
04:05pm, Wednesday, 05'th Aug 2026
MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2026.
PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system
09:05am, Wednesday, 05'th Aug 2026
Vega SPRQ-Nx chemistry to deliver up to 90 Gb per run at 40% lower cost per gigabase, with single-shift runs and new workflow controls for regulated labs Vega SPRQ-Nx chemistry to deliver up to 90 Gb
What's in Store for These 4 Healthcare Companies This Earnings Season?
04:11pm, Tuesday, 04'th Aug 2026
McKesson, Cencora, Solventum and PacBio head into earnings with resilient demand offset by tariffs, funding pressure and pricing challenges.
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives $1.83 Consensus PT from Brokerages
01:58am, Thursday, 30'th Jul 2026
Pacific Biosciences of California, Inc. (NASDAQ: PACB - Get Free Report) has been assigned a consensus recommendation of "Reduce" from the five research firms that are currently covering the company,
Pacific Biosciences of California (PACB) Laps the Stock Market: Here's Why
07:16pm, Tuesday, 28'th Jul 2026
Pacific Biosciences of California (PACB) reached $1.39 at the closing of the latest trading day, reflecting a +2.21% change compared to its last close.
PacBio to Participate in the Canaccord Genuity 46th Annual Growth Conference
04:05pm, Tuesday, 28'th Jul 2026
MENLO PARK, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate
Amova Asset Management Americas Inc. Has $9.22 Million Stock Position in Pacific Biosciences of California, Inc. $PACB
03:16am, Tuesday, 21'st Jul 2026
Amova Asset Management Americas Inc. cut its position in shares of Pacific Biosciences of California, Inc. (NASDAQ: PACB) by 9.9% during the undefined quarter, according to its most recent filing with
Here's Why Pacific Biosciences of California (PACB) Fell More Than Broader Market
07:16pm, Monday, 20'th Jul 2026
In the most recent trading session, Pacific Biosciences of California (PACB) closed at $1.36, indicating a -5.56% shift from the previous trading day.
PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026
04:05pm, Wednesday, 15'th Jul 2026
MENLO PARK, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2026 financial results on Wedn
